The EMAs CHMP has recommended for approval Two biosimilars, Tofidence (tocilizumab) and Wezenla (ustekinumab) https://t.co/mREclYdeCk https://t.co/zQX00Ys8oH
Links:
Meeting highlights from the Committee for Medicinal Products for Human Use (CHM…
https://buff.ly/3wAfKTF
May-14-2024
